UBS Group AG - SECOND SIGHT MED PRODS INC ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$11,0005,357
+6857.1%
0.00%
Q1 2022$0
-100.0%
77
-97.6%
0.00%
Q4 2021$5,0003,153
+3994.8%
0.00%
Q3 2021$0770.0%0.00%
Q2 2021$0
-100.0%
77
-96.7%
0.00%
Q1 2021$20,0002,356
+2959.7%
0.00%
Q4 2020$0
-100.0%
77
-99.9%
0.00%
Q3 2020$77,000
+3750.0%
89,804
+3462.2%
0.00%
Q2 2020$2,0002,521
+3174.0%
0.00%
Q1 2020$0770.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2022
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders